Skip to main content
Figure 2 | BMC Nephrology

Figure 2

From: The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data

Figure 2

Estimated proportion of patients surviving by levels of EPO administration. Although the differences were small, survival was best in those receiving a low dose of EPO (L = ≤ 12.1 103 units per week), slightly worse with a medium dose (M = 12.1–27.7 103 units per week), and worst in those receiving a high dose (H = > 27.7 103 units per week).

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us